The goal of the authors of the scale was to reflect the tumor mass and degree of renal involvement by measuring serum β2-microglobulin concentration and indirectly analyzing bone marrow microenvironment via albumin concentration, which is closely associated with IL-6 concentration. The gene discussed is HLA-G; the disease is neoplasm.